1. Home
  2. BDSX vs PCSC Comparison

BDSX vs PCSC Comparison

Compare BDSX & PCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • PCSC
  • Stock Information
  • Founded
  • BDSX 2005
  • PCSC 2024
  • Country
  • BDSX United States
  • PCSC United States
  • Employees
  • BDSX N/A
  • PCSC N/A
  • Industry
  • BDSX Precision Instruments
  • PCSC
  • Sector
  • BDSX Health Care
  • PCSC
  • Exchange
  • BDSX Nasdaq
  • PCSC NYSE
  • Market Cap
  • BDSX 115.4M
  • PCSC 114.2M
  • IPO Year
  • BDSX 2020
  • PCSC 2024
  • Fundamental
  • Price
  • BDSX $0.26
  • PCSC $10.70
  • Analyst Decision
  • BDSX Strong Buy
  • PCSC
  • Analyst Count
  • BDSX 5
  • PCSC 0
  • Target Price
  • BDSX $1.75
  • PCSC N/A
  • AVG Volume (30 Days)
  • BDSX 2.9M
  • PCSC 6.7K
  • Earning Date
  • BDSX 08-06-2025
  • PCSC 01-01-0001
  • Dividend Yield
  • BDSX N/A
  • PCSC N/A
  • EPS Growth
  • BDSX N/A
  • PCSC N/A
  • EPS
  • BDSX N/A
  • PCSC N/A
  • Revenue
  • BDSX $74,463,000.00
  • PCSC N/A
  • Revenue This Year
  • BDSX $17.29
  • PCSC N/A
  • Revenue Next Year
  • BDSX $29.33
  • PCSC N/A
  • P/E Ratio
  • BDSX N/A
  • PCSC $46.48
  • Revenue Growth
  • BDSX 35.76
  • PCSC N/A
  • 52 Week Low
  • BDSX $0.17
  • PCSC $10.02
  • 52 Week High
  • BDSX $2.04
  • PCSC $10.74
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 38.93
  • PCSC N/A
  • Support Level
  • BDSX $0.27
  • PCSC N/A
  • Resistance Level
  • BDSX $0.33
  • PCSC N/A
  • Average True Range (ATR)
  • BDSX 0.03
  • PCSC 0.00
  • MACD
  • BDSX 0.01
  • PCSC 0.00
  • Stochastic Oscillator
  • BDSX 19.54
  • PCSC 0.00

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About PCSC PERCEPTIVE CAP SOLUTIONS CORP

Perceptive Capital Solutions Corp is a blank check company.

Share on Social Networks: